Lexaria Bioscience Income Statement (2015-2026) | LEXX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025 Feb2026
Revenue & cost
Revenue (Quarter)
0.20M6.31M0.01M0.03M0.10M0.00M0.10M0.02M0.08M0.03M0.15M0.14M0.08M0.08M0.18M0.17M0.17M0.17M0.02M
Cost of Revenue (Quarter)
0.06M0.02M0.01M0.01M0.02M0.04M0.02M0.00M0.01M0.00M0.00M
Gross Profit (Quarter)
0.14M0.01M0.01M0.02M0.08M0.07M0.08M0.11M0.06M0.03M0.15M0.14M0.08M0.08M0.18M0.17M0.17M0.17M0.02M
Operating items
Amortization - Intangibles (Quarter)
0.00M0.00M
Depreciation & Amortization - Total (Quarter)
0.03M
Research & Development (Quarter)
0.45M0.44M0.46M0.28M0.75M0.36M0.83M0.70M1.64M0.50M0.57M0.25M0.57M0.97M1.95M1.69M2.72M1.88M0.67M0.48M
Selling, General & Administrative (Quarter)
2.26M0.87M1.55M1.20M1.75M0.46M0.95M0.64M0.83M0.64M0.71M0.57M1.25M1.32M0.92M1.24M1.21M0.98M0.90M1.00M
Other Operating Expenses (Quarter)
1.52M
Operating Expenses (Quarter)
2.71M1.31M2.01M1.47M2.50M0.82M1.78M1.34M2.47M1.14M1.29M0.81M1.83M2.29M2.87M2.93M3.92M2.86M1.57M1.47M
Operating Income (Quarter)
-2.57M-1.30M-2.00M-1.45M-2.42M-0.75M-1.70M-1.32M-2.40M-1.11M-1.14M-0.67M-1.74M-2.20M-2.69M-2.75M-3.75M-2.69M-1.57M-1.45M
EBIT (Quarter)
-2.57M-1.30M-2.00M-1.45M-2.42M-0.75M-1.70M-1.32M-2.40M-1.11M-1.14M-0.67M-1.74M-2.20M-2.69M-2.75M-3.75M-2.69M-1.57M-1.45M
Non-operating items
Non Operating Investment Income (Quarter)
-0.08M-0.00M0.00M-0.14M-0.05M0.02M-0.04M0.01M-0.02M0.03M-0.04M-0.01M-0.02M
Interest & Investment Income (Quarter)
0.01M-1.000.01M11.00190.000.00M12.000.00M
Other Non Operating Income (Quarter)
-0.07M0.01M0.02M-0.13M-0.05M0.02M-0.04M0.02M-0.02M0.03M-0.02M0.00M
Non Operating Income (Quarter)
-0.07M0.01M0.02M-0.13M-0.05M0.02M-0.04M0.02M-0.02M0.03M-0.04M-0.01M-0.02M0.00M
Net income details
EBT (Quarter)
-2.57M-1.30M-2.00M-1.45M-2.42M-0.75M-1.70M-1.32M-2.40M-1.11M-1.13M-0.67M-1.74M-2.20M-2.69M-2.75M-3.75M-2.69M-1.57M-1.45M
Tax Provisions (Quarter)
0.00M0.00M
Profit After Tax (Quarter)
-2.57M-1.18M-1.99M-1.43M-2.38M-1.40M-1.76M-1.30M-2.38M-1.29M-1.18M-0.65M-1.78M-2.20M-2.71M-2.72M-3.79M-2.71M-1.60M-1.45M
Income from Non-Controlling Interests (Quarter)
-0.01M-0.12M-0.01M-0.02M-0.04M-0.05M-0.01M-0.01M-0.01M-0.01M-0.01M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Income from Continuing Operations (Quarter)
-2.57M-1.30M-2.00M-1.45M-2.42M-0.75M-1.70M-1.32M-2.40M-1.11M-1.13M-0.67M-1.74M-2.20M-2.69M-2.75M-3.75M-2.69M-1.58M-1.45M
Consolidated Net Income (Quarter)
-2.00M-1.45M-2.42M-0.75M-1.70M-1.32M-2.40M-1.11M-1.13M-0.67M-1.74M-2.20M-2.69M-2.75M-3.75M-2.69M-1.58M-1.45M
Income towards Parent Company (Quarter)
-2.00M-1.45M-2.42M-0.75M-1.70M-1.32M-2.40M-1.11M-1.13M-0.67M-1.74M-2.20M-2.69M-2.75M-3.75M-2.69M-1.58M-1.45M
Net Income towards Common Stockholders (Quarter)
-2.56M-1.18M-1.99M1.43M-2.38M-1.47M1.80M1.30M2.40M1.20M1.20M0.60M1.80M2.20M2.70M2.70M3.80M2.70M1.60M1.40M
Additional items
EPS (Basic) (Quarter)
-0.50-0.24-0.35-0.25-0.98-0.610.300.540.370.270.220.090.300.370.910.360.520.370.160.13
EPS (Weighted Average and Diluted) (Quarter)
0.18-0.13-0.06-0.13-0.15-0.16-0.15-0.21-0.13-0.07-0.06
Shares Outstanding (Weighted Average) (Quarter)
5.10M2.42M2.42M2.42M2.42M5.95M2.41M6.44M4.52M5.54M6.63M5.93M5.93M2.95M7.56M7.30M7.30M10.06M11.09M
Shares Outstanding (Diluted Average) (Quarter)
6.61M9.05M10.77M13.86M12.38M16.67M17.51M18.30M18.00M21.38M22.90M
EBITDA (Quarter)
-2.54M-1.30M-2.00M-1.45M-2.42M-0.75M-1.76M-1.30M-2.37M-1.24M-1.17M-0.67M-1.78M-2.18M-2.71M-2.81M-3.75M-2.69M-1.60M-1.43M
Tax Rate (Quarter)
-0.11%-0.18%